HCR Wealth Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.4K | Hold |
17,000
| – | – | ﹤0.01% | 235 |
|
|
2025
Q1 | $19.7K | Hold |
17,000
| – | – | ﹤0.01% | 230 |
|
|
2024
Q4 | $21.6K | Hold |
17,000
| – | – | ﹤0.01% | 228 |
|
|
2024
Q3 | $58K | Hold |
17,000
| – | – | 0.01% | 227 |
|
|
2024
Q2 | $79.4K | Hold |
17,000
| – | – | 0.01% | 218 |
|
|
2024
Q1 | $126K | Sell |
17,000
-5,000
| -23% | -$37.1K | 0.02% | 218 |
|
|
2023
Q4 | $223K | Hold |
22,000
| – | – | 0.04% | 185 |
|
|
2023
Q3 | $172K | Hold |
22,000
| – | – | 0.04% | 165 |
|
|
2023
Q2 | $181K | Hold |
22,000
| – | – | 0.03% | 168 |
|
|
2023
Q1 | $160K | Hold |
22,000
| – | – | 0.03% | 167 |
|
|
2022
Q4 | $195K | Hold |
22,000
| – | – | 0.04% | 166 |
|
|
2022
Q3 | $269K | Hold |
22,000
| – | – | 0.06% | 141 |
|
|
2022
Q2 | $260K | Buy |
22,000
+1,000
| +5% | +$11.8K | 0.05% | 147 |
|
|
2022
Q1 | $399K | Buy |
21,000
+1,250
| +6% | +$23.8K | 0.07% | 139 |
|
|
2021
Q4 | $524K | Hold |
19,750
| – | – | 0.08% | 134 |
|
|
2021
Q3 | $811K | Sell |
19,750
-1,300
| -6% | -$53.4K | 0.14% | 109 |
|
|
2021
Q2 | $1.19M | Buy |
21,050
+1,300
| +7% | +$73.6K | 0.21% | 92 |
|
|
2021
Q1 | $830K | Hold |
19,750
| – | – | 0.16% | 100 |
|
|
2020
Q4 | $1.39M | Hold |
19,750
| – | – | 0.29% | 70 |
|
|
2020
Q3 | $554K | Hold |
19,750
| – | – | 0.13% | 98 |
|
|
2020
Q2 | $609K | Hold |
19,750
| – | – | 0.14% | 87 |
|
|
2020
Q1 | $392K | Buy |
+19,750
| New | +$392K | 0.11% | 100 |
|